She was initially thought to have either type 2 diabetes or maturity-onset diabetes of the young, and so treated with a sulfonylurea with good results before the addition of metformin and subsequent conversion to basal-bolus insulin therapy because of raised postprandial blood glucose levels. The gene discussed is INS; the disease is type 2 diabetes mellitus.